These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
370 related items for PubMed ID: 8658076
41. Treatment of HIV-related fluconazole-resistant oral candidosis with D0870, a new triazole antifungal. Cartledge JD, Denning DW, Dupont B, Clumeck N, De Wit S, Midgley J, Hawkins DA, Gazzard BG. AIDS; 1998 Mar 05; 12(4):411-6. PubMed ID: 9520171 [Abstract] [Full Text] [Related]
45. Change in fluconazole susceptibility patterns and genetic relationship among oral Candida albicans isolates. Diaz-Guerra TM, Martinez-Suarez JV, Laguna F, Valencia E, Rodriguez-Tudela JL. AIDS; 1998 Sep 10; 12(13):1601-10. PubMed ID: 9764778 [Abstract] [Full Text] [Related]
46. [Comparison of three antifungal susceptibility testing methods for the in vitro testing of Candida isolates from patients with HIV infection]. Ruhnke M, Schmidt-Westhausen A, Trautmann M. Mycoses; 1996 Sep 10; 39 Suppl 2():47-50. PubMed ID: 9198745 [Abstract] [Full Text] [Related]
47. Detection and significance of fluconazole resistance in oropharyngeal candidiasis in human immunodeficiency virus-infected patients. Revankar SG, Kirkpatrick WR, McAtee RK, Dib OP, Fothergill AW, Redding SW, Rinaldi MG, Patterson TF. J Infect Dis; 1996 Oct 10; 174(4):821-7. PubMed ID: 8843222 [Abstract] [Full Text] [Related]
51. Antifungal effect of Trachyspermum ammi against susceptible and fluconazole-resistant strains of Candida albicans. Sharifzadeh A, Khosravi AR, Shokri H, Sharafi G. J Mycol Med; 2015 Jun 10; 25(2):143-50. PubMed ID: 25982599 [Abstract] [Full Text] [Related]
52. In vitro activity of a new antifungal triazole, D0870, against Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus. Barchiesi F, Colombo AL, McGough DA, Fothergill AW, Rinaldi MG. Antimicrob Agents Chemother; 1994 Nov 10; 38(11):2553-6. PubMed ID: 7872746 [Abstract] [Full Text] [Related]
54. Relative growth measurement of Candida species in a single concentration of fluconazole predicts the clinical response to fluconazole in HIV infected patients with oral candidosis. Cartledge JD, Midgley J, Gazzard BG. J Antimicrob Chemother; 1996 Feb 10; 37(2):275-83. PubMed ID: 8707737 [Abstract] [Full Text] [Related]
56. [Itraconazole suspension in the treatment of HIV-infected patients with fluconazole-resistant oropharyngeal candidiasis and esophagitis]. Eichel M, Just-Nübling G, Helm EB, Stille W. Mycoses; 1996 Feb 10; 39 Suppl 1():102-6. PubMed ID: 8767280 [Abstract] [Full Text] [Related]
57. Fluconazole-resistant Candida in AIDS patients. Report of two cases. Heinic GS, Stevens DA, Greenspan D, MacPhail LA, Dodd CL, Stringari S, Strull WM, Hollander H. Oral Surg Oral Med Oral Pathol; 1993 Dec 10; 76(6):711-5. PubMed ID: 8284074 [Abstract] [Full Text] [Related]
58. Itraconazole cyclodextrin solution for fluconazole-refractory oropharyngeal candidiasis in AIDS: correlation of clinical response with in vitro susceptibility. Phillips P, Zemcov J, Mahmood W, Montaner JS, Craib K, Clarke AM. AIDS; 1996 Oct 10; 10(12):1369-76. PubMed ID: 8902066 [Abstract] [Full Text] [Related]